Back to List View Graph View

Klebsiella pneumoniae

Klebsiella pneumoniae is a Gram-negative, encapsulated bacterium in the family Enterobacteriaceae and a clinically important opportunistic pathogen.

Where the papers sit

9 papers from the last 6 months study klebsiella pneumoniae directly · updated from PubMed 15 Nov 2026

Study type 0 clinical trials · 1 human data · 8 preclinical

Themes one subject · 1 new direction

Those 9 are all about one subject.

  • Klebsiella Infection Control

    Preclinical control of Klebsiella is being pursued through maternal vaccination, novel antibacterials, targeted delivery and rapid detection. Recurring targets include multidrug resistance, efflux pumps, biofilms, virulence-factor expression and inflammation. Nanoemulsions, nanoparticles, essential oils, rifampicin-loaded exosomes and engineered macrophages broaden treatment beyond conventional antibiotics. The work remains exploratory, with efficacy shown mainly in laboratory systems and animal models rather than an established clinical strategy.

    9 papers

NEW DIRECTION

Klebsiella pneumoniae becomes a target of maternal immunoprophylaxis rather than only post-infection treatment or detection

The murine maternal-immunization and pup-challenge study assumed that protection against K. pneumoniae neonatal sepsis could be evaluated through antibodies transferred from vaccinated dams; instead of treating established infection with an antimicrobial, it showed that maternal K1- and K2-capsular polysaccharide bioconjugate vaccination transferred antibodies that protected offspring from lethal sepsis for at least six weeks after birth. This places K. pneumoniae in a preventive maternal–neonatal vaccination strategy, extending its role beyond the set’s direct antibacterial, resistance, virulence-modulation, diagnostic, and disease-treatment models 42873859Oct.

Papers

The 9 papers from the last 6 months that study klebsiella pneumoniae directly, newest first, by theme and by study type. Study types come from PubMed publication types and MeSH headings.

By theme

Klebsiella Infection Control (9)
  1. Maternal vaccination with capsular polysaccharide bioconjugates protects against murine Klebsiella pneumoniae neonatal sepsis. Science advances · 14 Oct 2026 PMID 42873859
  2. Phenotypic and molecular detection of efflux pump and expression profiling genes in Klebsiella pneumoniae exposed to ciprofloxacin and amoxicillin/clavulanic acid. Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2 Sept 2026 PMID 42684540
  3. Nanoemulsion-Mediated Suppression of Multidrug-Resistant Klebsiella pneumoniae via Oxygen Consumption Reduction and Biofilm Inhibition. Current microbiology · 30 Jul 2026 PMID 42530666
  4. Programmable macrophage interface engineering enables targeted antibacterial therapy in immunosuppressed infections. Science bulletin · 15 Jul 2026 PMID 42457472
  5. Spectroscopic discrimination of bacterial species of variable pathogenicity through explainable machine learning. Nanoscale · 9 Jul 2026 PMID 42422903
  6. Co-encapsulation of formic acid and Satureja hortensis essential oil enhances antibacterial and anti-inflammatory activities against Salmonella enterica. Journal of microbiological methods · 16 Jun 2026 PMID 42302970
  7. ADMCs-derived exosomal vesicles encapsulated with rifampicin to attenuate Klebsiella pneumonia-induced pediatric lung inflammation: In-vitro and In vivo studies. Microbial pathogenesis · 10 Jun 2026 PMID 42269980
  8. The role of biosynthesized zinc oxide nanoparticles in modulating the expression of virulence factors in multidrug-resistant Klebsiellapneumoniae. Microbial pathogenesis · 10 Jun 2026 PMID 42269978
  9. Design, synthesis and antibacterial evaluation of novel unsaturated butenolide-fatty amine hybrids against multidrug-resistant pathogens. Bioorganic & medicinal chemistry letters · 21 May 2026 PMID 42167554

By study type

Human data, design not indexed (1)
  1. Phenotypic and molecular detection of efflux pump and expression profiling genes in Klebsiella pneumoniae exposed to ciprofloxacin and amoxicillin/clavulanic acid. Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2 Sept 2026 PMID 42684540
Preclinical: animal, cell and lab studies (8)
  1. Maternal vaccination with capsular polysaccharide bioconjugates protects against murine Klebsiella pneumoniae neonatal sepsis. Science advances · 14 Oct 2026 PMID 42873859
  2. Nanoemulsion-Mediated Suppression of Multidrug-Resistant Klebsiella pneumoniae via Oxygen Consumption Reduction and Biofilm Inhibition. Current microbiology · 30 Jul 2026 PMID 42530666
  3. Programmable macrophage interface engineering enables targeted antibacterial therapy in immunosuppressed infections. Science bulletin · 15 Jul 2026 PMID 42457472
  4. Spectroscopic discrimination of bacterial species of variable pathogenicity through explainable machine learning. Nanoscale · 9 Jul 2026 PMID 42422903
  5. Co-encapsulation of formic acid and Satureja hortensis essential oil enhances antibacterial and anti-inflammatory activities against Salmonella enterica. Journal of microbiological methods · 16 Jun 2026 PMID 42302970
  6. ADMCs-derived exosomal vesicles encapsulated with rifampicin to attenuate Klebsiella pneumonia-induced pediatric lung inflammation: In-vitro and In vivo studies. Microbial pathogenesis · 10 Jun 2026 PMID 42269980
  7. The role of biosynthesized zinc oxide nanoparticles in modulating the expression of virulence factors in multidrug-resistant Klebsiellapneumoniae. Microbial pathogenesis · 10 Jun 2026 PMID 42269978
  8. Design, synthesis and antibacterial evaluation of novel unsaturated butenolide-fatty amine hybrids against multidrug-resistant pathogens. Bioorganic & medicinal chemistry letters · 21 May 2026 PMID 42167554